I was excited to hear at the Alliance for CME annual conference about the community's new advocacy initiatives, and in particular, the drive to collect data to demonstrate CME's positive impact on patient care and to determine the prevalence of commercial bias. CME leaders were forthright in acknowledging that they don't know what the data will show — it may, in fact, reveal that the Senate Finance Committee and other critics are correct in their assessment that commercial support erodes ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.